Back to search results

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia · Acute Myeloid Leukemia, in Relapse

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (David Avigan, MD) · davigan@bidmc.harvard.edu · 617-667-9920
    Contact: Principal Investigator (David Avigan, MD)
Study leads

  • David Avigan, MD

    Principal Investigator

    Beth Israel Deaconess Medical Center

View source on ClinicalTrials.gov(opens in a new tab)